Minmin Li, MS, PMP, currently serves as a Program Manager at ABL since June 2024. Previously, as a Senior Project Manager at Sirnaomics from March 2022 to May 2024, Minmin developed comprehensive development and manufacturing plans for RNA-based therapeutics, overseeing critical processes such as technology transfer and clinical trial support. Minmin's experience as a Project Manager at ABL Inc. from August 2017 to March 2022 included managing preclinical biologics and vaccine development projects, while earlier tenure at Clyde Bergemann Power Group involved designing and managing emission control solutions. Minmin holds a Master’s degree in Chemical Engineering from Brigham Young University and a Bachelor’s degree in Chemical Engineering from Sichuan University.